Cargando…
Recombinant E2 protein enhances protective efficacy of inactivated bovine viral diarrhea virus 2 vaccine in a goat model
BACKGROUND: Inactivated and subunit bovine viral diarrhea virus (BVDV) vaccines have shown limited protective efficacy. This study aimed to evaluate the effectiveness of a vaccine containing both inactivated BVDV (iBVDV) and baculovirus-expressed recombinant E2 (rE2), an important BVDV antigen with...
Autores principales: | Chung, Yao-Chi, Cheng, Li-Ting, Zhang, Jia-Yu, Wu, Yue-Jyun, Liu, Shyh-Shyan, Chu, Chun-Yen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019225/ https://www.ncbi.nlm.nih.gov/pubmed/29940938 http://dx.doi.org/10.1186/s12917-018-1520-2 |
Ejemplares similares
-
Experimental infection of pregnant goats with bovine viral diarrhea virus (BVDV) 1 or 2
por: Passler, Thomas, et al.
Publicado: (2014) -
Genetic Diversity of Bovine Viral Diarrhea Virus Infection in Goats in Southwestern China
por: Deng, Yu, et al.
Publicado: (2018) -
Immune protection induced by E2 recombinant glycoprotein of bovine viral diarrhea virus in a murine model
por: Gómez-Romero, Ninnet, et al.
Publicado: (2023) -
Control of Bovine Viral Diarrhea
por: Moennig, Volker, et al.
Publicado: (2018) -
Bovine Viral Diarrhea Virus
por: LIESS, B.
Publicado: (1990)